Statin
Showing 1 - 25 of 1,801
Drug Adherence Trial (Red yeast rice extract initial therapy followed later on by statin therapy, Statin therapy)
Not yet recruiting
- Moderate 10-year Atherosclerotic Cardiovascular Disease Risk Patients
- Red yeast rice extract initial therapy followed later on by statin therapy
- Statin therapy
- (no location specified)
Apr 26, 2023
Vaccine Response Trial in Atlanta (Atorvastatin, Quadrivalent seasonal influenza vaccine)
Not yet recruiting
- Vaccine Response
- Atorvastatin
- Quadrivalent seasonal influenza vaccine
-
Atlanta, GeorgiaHope Clinic
Aug 29, 2023
Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation Trial in Seoul
Not yet recruiting
- Coronary Artery Disease Requiring Coronary Revascularization With Newer Generation DES Implantation
- ezetimibe/high-intensity statin combination therapy (ezetimibe 10mg plus atoravastatin 40mg)
- high-intensity statin monotherapy (atoravastatin 40mg)
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Mar 21, 2023
Coronary Artery Calcification, Metabolic Syndrome, Dyslipidemias Trial (Guideline directed statin therapy, High intensity statin
Not yet recruiting
- Coronary Artery Calcification
- +2 more
- Guideline directed statin therapy
- High intensity statin plus ezetimibe therapy
- (no location specified)
Apr 25, 2023
Diabetes, Pre Diabetes, ASCVD Trial (high-intensity statin arm, low-intensity statin plus ezetimibe)
Not yet recruiting
- Diabetes Mellitus
- +2 more
- high-intensity statin arm
- low-intensity statin plus ezetimibe
- (no location specified)
Oct 12, 2022
Physical Activity Levels and Statin Therapy
Active, not recruiting
- Cardiovascular Diseases
- +2 more
- Physical activity monitoring
-
Nijmegen, NetherlandsDepartment of Physiology
Nov 15, 2022
Coronary Artery Diseasse Trial in Seoul (fixed high potent statin therapy, targeted LDL-C goal statin)
Active, not recruiting
- Coronary Artery Diseasse
- fixed high potent statin therapy
- targeted LDL-C goal statin
-
Seoul, Korea, Republic ofDivision of Cardiology, Department of Internal Medicine, Yonsei
Jul 19, 2022
Diabetes, Type 2, Dyslipidemia Associated With Type II Diabetes, Statin Adverse Reaction Trial in Tunis (Atorvastatin 40 Mg Oral
Completed
- Diabetes Mellitus, Type 2
- +5 more
- Atorvastatin 40 Mg Oral Tablet
-
Tunis, TunisiaUniversity Hospital La Rabta
Apr 7, 2023
Atherosclerosis Trial in Essen (Medication management app (mediteo m+, Mediteo GmbH, Heidelberg))
Recruiting
- Atherosclerosis
- Medication management app (mediteo m+, Mediteo GmbH, Heidelberg)
-
Essen, Nordrhein-Westfalen, GermanyUniversity Hospital, Essen
Mar 8, 2023
Extra Alirocumab in Addition to Statin Therapy in Symptomatic
Recruiting
- Stroke
- Intracranial Atherosclerotic Stenosis
-
Nanjing, Jiangsu, Chinathe First affiliated hospital of Nanjing Medical University
Sep 24, 2023
Doxorubicin Induced Cardiomyopathy Trial in Cairo (Atorvastatin 40 Mg Oral Tablet, Placebo)
Recruiting
- Doxorubicin Induced Cardiomyopathy
- Atorvastatin 40 Mg Oral Tablet
- Placebo
-
Cairo, EgyptAin Shams University hospitals
Apr 4, 2023
Coronary Artery Disease Trial in Boston (Rosuvastatin, Colchicine)
Not yet recruiting
- Coronary Artery Disease
-
Boston, MassachusettsMassachusetts General Hospital
Apr 28, 2023
Combined Statin and PD-1/PD-L1 Inhibitors in Treating Non-small
Recruiting
- Lung Cancer
- Statin
-
Yiwu, Zhejiang, ChinaThe Fourth Affiliated Hospital of Zhejiang University
Dec 16, 2022
Intracranial Atherosclerosis, Atherosclerotic Plaque, Stenosis Trial in Nanjing (Alirocumab, Atorvastatin)
Not yet recruiting
- Intracranial Atherosclerosis
- +2 more
-
Nanjing, Jiangsu, Chinathe First affiliated hospital of Nanjing Medical University
Oct 10, 2023
Quality of Life Trial in Tanta (Atorvastatin 20mg, Placebo)
Recruiting
- Quality of Life
- Atorvastatin 20mg
- Placebo
-
Tanta, EgyptTanta University
Nov 3, 2022
Status of Dyslipidemia Following Administration of Statin and
Recruiting
- Dyslipidemias
- Statin+Ezetimibe compound
-
Seoul, Korea, Republic ofKorea University Guro Hospital
Nov 7, 2022
Primary Sclerosing Cholangitis, IBD Trial in Stanford (Rosuvastatin)
Recruiting
- Primary Sclerosing Cholangitis
- Inflammatory Bowel Diseases
-
Stanford, CaliforniaStanford University
Jun 12, 2023
Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis Trial in Nanjing (Evolocumab, Atorvastatin)
Not yet recruiting
- Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis
-
Nanjing, Jiangsu, Chinathe First affiliated hospital of Nanjing Medical University
Feb 14, 2023
Statin Treatment for Primary Prevention Trial in Bern (Statin discontinuation)
Not yet recruiting
- Statin Treatment for Primary Prevention
- Statin discontinuation
-
Bern, SwitzerlandUniversity Hospital of Bern, University of Bern
Jul 28, 2022
Tuberculosis Trial in Johannesburg (Pravastatin)
Completed
- Tuberculosis
-
Johannesburg, South AfricaChris Hani Baragwanath Hospital
Sep 26, 2022
Statin Treatment for Primary Prevention Trial in Bern (Statin discontinuation)
Recruiting
- Statin Treatment for Primary Prevention
- Statin discontinuation
-
Bern, SwitzerlandUniversity Hospital of Bern, University of Bern
Aug 2, 2022
Acute Coronary Syndrome, Hyperlipidemias, Percutaneous Coronary Intervention Trial in Nanjing (Placebo plus high-intensity
Not yet recruiting
- Acute Coronary Syndrome
- +3 more
- Placebo plus high-intensity statin
- PCSK 9 Inhibitor plus high-intensity statin
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Aug 1, 2022
Atheroscleroses, Coronary Trial in Seoul (Rosuvastatin and Ezetimibe, Rosuvastatin)
Active, not recruiting
- Atheroscleroses, Coronary
- Rosuvastatin and Ezetimibe
- Rosuvastatin
-
Seoul, Korea, Republic of
- +1 more
Oct 1, 2022
Coronary Artery Disease, Dyslipidemias Trial in Yongin (a high dose of statin/ezetimib)
Recruiting
- Coronary Artery Disease
- Dyslipidemias
- a high dose of statin/ezetimib
-
Yongin, Gyeonggi-do, Korea, Republic ofYongin Severance Hospital
Jun 14, 2023
Intracerebral Hemorrhage, Statins Trial in Beijing, Baoding (Statin)
Recruiting
- Intracerebral Hemorrhage
- Statins
- Statin
-
Beijing, Beijing, China
- +2 more
Jun 7, 2022